{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:40:49Z","timestamp":1783996849778,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011096","name":"Philippine Council for Health Research and Development","doi-asserted-by":"crossref","award":["2022-03-A2-PCHRD-EASIA-HR-9093"],"award-info":[{"award-number":["2022-03-A2-PCHRD-EASIA-HR-9093"]}],"id":[{"id":"10.13039\/501100011096","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011096","name":"Philippine Council for Health Research and Development","doi-asserted-by":"crossref","award":["2022-03-A2-PCHRD-EASIA-HR-9093"],"award-info":[{"award-number":["2022-03-A2-PCHRD-EASIA-HR-9093"]}],"id":[{"id":"10.13039\/501100011096","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011096","name":"Philippine Council for Health Research and Development","doi-asserted-by":"crossref","award":["2022-03-A2-PCHRD-EASIA-HR-9093"],"award-info":[{"award-number":["2022-03-A2-PCHRD-EASIA-HR-9093"]}],"id":[{"id":"10.13039\/501100011096","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011096","name":"Philippine Council for Health Research and Development","doi-asserted-by":"crossref","award":["2022-03-A2-PCHRD-EASIA-HR-9093"],"award-info":[{"award-number":["2022-03-A2-PCHRD-EASIA-HR-9093"]}],"id":[{"id":"10.13039\/501100011096","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["GNT2018695"],"award-info":[{"award-number":["GNT2018695"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["GNT2018695"],"award-info":[{"award-number":["GNT2018695"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"e-Asia Joint Research Program"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["INT-9531011"],"award-info":[{"award-number":["INT-9531011"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012789","name":"Veski","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10934-2","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:39:01Z","timestamp":1744807141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Applying novel Plasmodium Vivax serological exposure markers to quantify residual malaria transmission in the Philippines through repeated health facility surveys: the SMaRT study protocol"],"prefix":"10.1186","volume":"25","author":[{"given":"Jhobert","family":"Bernal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lourdes","family":"Macalinao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Cosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beaulah","family":"Boncayao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fe Esperanza J.","family":"Espino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Stresman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Luchavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea J.","family":"Longley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"10934_CR1","unstructured":"World Health Organization. World malaria report 2021. 2021."},{"issue":"1","key":"10934_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12916-020-01710-x","volume":"18","author":"SJ Rogerson","year":"2020","unstructured":"Rogerson SJ, Beeson JG, Laman M, Poespoprodjo JR, William T, Simpson JA, et al. Identifying and combating the impacts of COVID-19 on malaria. BMC Med. 2020;18(1):239.","journal-title":"BMC Med"},{"issue":"6","key":"10934_CR3","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","volume":"36","author":"RN Price","year":"2020","unstructured":"Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium Vivax in the era of the shrinking P. falciparum map. Trends Parasitol. 2020;36(6):560\u201370.","journal-title":"Trends Parasitol"},{"key":"10934_CR4","unstructured":"Department of Health. National Strategic Plan for the Control and Elimination of Malaria in the Philippines 2020\u20132022. 2020."},{"key":"10934_CR5","unstructured":"Philippines Department of Health.\u2013 National Malaria Control and Elimination Program. Malaria Transition, Elimination and Sustainability Plan 2023\u20132028. 2023."},{"issue":"10","key":"10934_CR6","doi-asserted-by":"publisher","first-page":"e1001891","DOI":"10.1371\/journal.pmed.1001891","volume":"12","author":"LJ Robinson","year":"2015","unstructured":"Robinson LJ, Wampfler R, Betuela I, Karl S, White MT, Li Wai Suen CS, et al. Strategies for Understanding and reducing the plasmodium Vivax and plasmodium ovale hypnozoite reservoir in Papua new Guinean children: a randomised placebo-controlled trial and mathematical model. PLoS Med. 2015;12(10):e1001891.","journal-title":"PLoS Med"},{"key":"10934_CR7","doi-asserted-by":"publisher","first-page":"102526","DOI":"10.1016\/j.parint.2021.102526","volume":"87","author":"F Angrisano","year":"2022","unstructured":"Angrisano F, Robinson LJ. Plasmodium vivax - How hidden reservoirs hinder global malaria elimination. Parasitol Int. 2022;87:102526.","journal-title":"Parasitol Int"},{"issue":"12","key":"10934_CR8","doi-asserted-by":"publisher","first-page":"e0010990","DOI":"10.1371\/journal.pntd.0010990","volume":"16","author":"E Stadler","year":"2022","unstructured":"Stadler E, Cromer D, Mehra S, Adekunle AI, Flegg JA, Anstey NM, et al. Population heterogeneity in plasmodium Vivax relapse risk. PLoS Negl Trop Dis. 2022;16(12):e0010990.","journal-title":"PLoS Negl Trop Dis"},{"key":"10934_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/1475-2875-12-383","volume":"12","author":"MS Hsiang","year":"2013","unstructured":"Hsiang MS, Hwang J, Tao AR, Liu Y, Bennett A, Shanks GD, et al. Mass drug administration for the control and elimination of plasmodium Vivax malaria: an ecological study from Jiangsu Province, China. Malar J. 2013;12:383.","journal-title":"Malar J"},{"issue":"3","key":"10934_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S1473-3099(21)00358-3","volume":"22","author":"JR Poespoprodjo","year":"2022","unstructured":"Poespoprodjo JR, Burdam FH, Candrawati F, Ley B, Meagher N, Kenangalem E, et al. Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and Vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial. Lancet Infect Dis. 2022;22(3):367\u201376.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10934_CR11","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/cid\/ciy231","volume":"67","author":"I Sutanto","year":"2018","unstructured":"Sutanto I, Kosasih A, Elyazar IRF, Simanjuntak DR, Larasati TA, Dahlan MS, et al. Negligible impact of mass screening and treatment on mesoendemic malaria transmission at West Timor in Eastern Indonesia: A Cluster-Randomized trial. Clin Infect Dis. 2018;67(9):1364\u201372.","journal-title":"Clin Infect Dis"},{"key":"10934_CR12","doi-asserted-by":"publisher","first-page":"102492","DOI":"10.1016\/j.parint.2021.102492","volume":"87","author":"Y Tayipto","year":"2022","unstructured":"Tayipto Y, Liu Z, Mueller I, Longley RJ. Serology for plasmodium Vivax surveillance: A novel approach to accelerate towards elimination. Parasitol Int. 2022;87:102492.","journal-title":"Parasitol Int"},{"issue":"5","key":"10934_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41591-020-0841-4","volume":"26","author":"RJ Longley","year":"2020","unstructured":"Longley RJ, White MT, Takashima E, Brewster J, Morita M, Harbers M, et al. Development and validation of serological markers for detecting recent plasmodium Vivax infection. Nat Med. 2020;26(5):741\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"10934_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-017-1826-8","volume":"16","author":"RJ Longley","year":"2017","unstructured":"Longley RJ, Fran\u00e7a CT, White MT, Kumpitak C, Sa-Angchai P, Gruszczyk J, et al. Asymptomatic plasmodium Vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of Western Thailand. Malar J. 2017;16(1):1\u201313.","journal-title":"Malar J"},{"issue":"9","key":"10934_CR15","doi-asserted-by":"publisher","first-page":"e0005888","DOI":"10.1371\/journal.pntd.0005888","volume":"11","author":"RJ Longley","year":"2017","unstructured":"Longley RJ, White MT, Takashima E, Morita M, Kanoi BN, Li Wai Suen CSN, et al. Naturally acquired antibody responses to more than 300 plasmodium Vivax proteins in three geographic regions. PLoS Negl Trop Dis. 2017;11(9):e0005888.","journal-title":"PLoS Negl Trop Dis"},{"key":"10934_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-10-297","volume":"10","author":"NJ White","year":"2011","unstructured":"White NJ. Determinants of relapse periodicity in plasmodium Vivax malaria. Malar J. 2011;10:297.","journal-title":"Malar J"},{"issue":"1","key":"10934_CR17","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.1038\/s41467-024-51015-3","volume":"15","author":"SV Siegel","year":"2024","unstructured":"Siegel SV, Trimarsanto H, Amato R, Murie K, Taylor AR, Sutanto E, et al. Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of plasmodium Vivax malaria parasites. Nat Commun. 2024;15(1):6757.","journal-title":"Nat Commun"},{"issue":"7","key":"10934_CR18","doi-asserted-by":"publisher","first-page":"e0010648","DOI":"10.1371\/journal.pntd.0010648","volume":"16","author":"R Noviyanti","year":"2022","unstructured":"Noviyanti R, Carey-Ewend K, Trianty L, Parobek C, Puspitasari AM, Balasubramanian S, et al. Hypnozoite depletion in successive plasmodium Vivax relapses. PLoS Negl Trop Dis. 2022;16(7):e0010648.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10934_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01611-z","volume":"18","author":"T Druetz","year":"2020","unstructured":"Druetz T, Stresman G, Ashton RA, Van Den Hoogen LL, Joseph V, Fayette C, et al. Programmatic options for monitoring malaria in elimination settings: easy access group surveys to investigate plasmodium falciparum epidemiology in two regions with differing endemicity in Haiti. BMC Med. 2020;18(1):1\u201314.","journal-title":"BMC Med"},{"issue":"1","key":"10934_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12942-018-0141-0","volume":"17","author":"KM Fornace","year":"2018","unstructured":"Fornace KM, Surendra H, Abidin TR, Reyes R, Macalinao MLM, Stresman G, et al. Use of mobile technology-based participatory mapping approaches to geolocate health facility attendees for disease surveillance in low resource settings. Int J Health Geogr. 2018;17(1):21.","journal-title":"Int J Health Geogr"},{"issue":"1","key":"10934_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-019-1482-7","volume":"18","author":"H Surendra","year":"2020","unstructured":"Surendra H, Supargiyono, Ahmad RA, Kusumasari RA, Rahayujati TB, Damayanti SY, et al. Using health facility-based serological surveillance to predict receptive areas at risk of malaria outbreaks in elimination areas. BMC Med. 2020;18(1):1\u201314.","journal-title":"BMC Med"},{"issue":"3","key":"10934_CR22","first-page":"968","volume":"104","author":"RA Reyes","year":"2021","unstructured":"Reyes RA, Fornace KM, Macalinao MLM, Boncayao BL, de la Fuente ES, Sabanal HM, et al. Enhanced health facility surveys to support malaria control and elimination across different transmission settings in the Philippines. Am J Trop Med Hyg. 2021;104(3):968\u201378.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10934_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/s12879-022-07581-2","volume":"22","author":"RA Ahmad","year":"2022","unstructured":"Ahmad RA, Nelli L, Surendra H, Arisanti RR, Lesmanawati DAS, Byrne I, et al. A framework for evaluating health system surveillance sensitivity to support public health decision-making for malaria elimination: a case study from Indonesia. BMC Infect Dis. 2022;22(1):619.","journal-title":"BMC Infect Dis"},{"key":"10934_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12936-015-0661-z","volume":"14","author":"N Sep\u00falveda","year":"2015","unstructured":"Sep\u00falveda N, Drakeley C. Sample size determination for estimating antibody seroconversion rate under stable malaria transmission intensity. Malar J. 2015;14:141.","journal-title":"Malar J"},{"key":"10934_CR25","doi-asserted-by":"publisher","first-page":"1208822","DOI":"10.3389\/fimmu.2023.1208822","volume":"14","author":"CM Leonard","year":"2023","unstructured":"Leonard CM, Uhomoibhi P, Abubakar A, Ogunniyi A, Mba N, Greby SM, et al. Dynamics of IgG antibody response against plasmodium antigens among Nigerian infants and young children. Front Immunol. 2023;14:1208822.","journal-title":"Front Immunol"},{"issue":"2","key":"10934_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0166-6851(93)90050-8","volume":"58","author":"G Snounou","year":"1993","unstructured":"Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol. 1993;58(2):283\u201392.","journal-title":"Mol Biochem Parasitol"},{"issue":"5","key":"10934_CR27","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1128\/JCM.02316-06","volume":"45","author":"A Calderaro","year":"2007","unstructured":"Calderaro A, Piccolo G, Perandin F, Gorrini C, Peruzzi S, Zuelli C, et al. Genetic polymorphisms influence plasmodium ovale PCR detection accuracy. J Clin Microbiol. 2007;45(5):1624\u20137.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10934_CR28","doi-asserted-by":"publisher","first-page":"e1002015","DOI":"10.1371\/journal.ppat.1002015","volume":"7","author":"KS Lee","year":"2011","unstructured":"Lee KS, Divis PC, Zakaria SK, Matusop A, Julin RA, Conway DJ, et al. Plasmodium Knowlesi: reservoir hosts and tracking the emergence in humans and macaques. PLoS Pathog. 2011;7(4):e1002015.","journal-title":"PLoS Pathog"},{"issue":"12","key":"10934_CR29","doi-asserted-by":"publisher","first-page":"e0238010","DOI":"10.1371\/journal.pone.0238010","volume":"15","author":"R Mazhari","year":"2020","unstructured":"Mazhari R, Brewster J, Fong R, Bourke C, Liu ZSJ, Takashima E, et al. A comparison of non-magnetic and magnetic beads for measuring IgG antibodies against plasmodium Vivax antigens in a multiplexed bead-based assay using luminex technology (Bio-Plex 200 or MAGPIX). PLoS ONE. 2020;15(12):e0238010.","journal-title":"PLoS ONE"},{"key":"10934_CR30","first-page":"100792","volume":"37","author":"MLM Macalinao","year":"2023","unstructured":"Macalinao MLM, Fornace KM, Reyes RA, Hall T, Bareng APN, Adams JH, et al. Analytical approaches for antimalarial antibody responses to confirm historical and recent malaria transmission: an example from the Philippines. Lancet Reg Health West Pac. 2023;37:100792.","journal-title":"Lancet Reg Health West Pac"},{"key":"10934_CR31","doi-asserted-by":"publisher","first-page":"643501","DOI":"10.3389\/fmicb.2021.643501","volume":"12","author":"S Chotirat","year":"2021","unstructured":"Chotirat S, Nekkab N, Kumpitak C, Hietanen J, White MT, Kiattibutr K, et al. Application of 23 novel serological markers for identifying recent exposure to plasmodium Vivax parasites in an endemic population of Western Thailand. Front Microbiol. 2021;12:643501.","journal-title":"Front Microbiol"},{"issue":"2","key":"10934_CR32","first-page":"1","volume":"15","author":"J Rosado","year":"2020","unstructured":"Rosado J, White MT, Longley RJ, Lacerda M, Monteiro W, Brewster J, et al. Heterogeneity in response to serological exposure markers of recent plasmodium Vivax infections in contrasting epidemiological contexts. PLoS Negl Trop Dis. 2020;15(2):1\u201323.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10934_CR33","doi-asserted-by":"publisher","first-page":"e0248218","DOI":"10.1371\/journal.pone.0248218","volume":"16","author":"F Amini","year":"2021","unstructured":"Amini F, Auma E, Hsia Y, Bilton S, Hall T, Ramkhelawon L, et al. Reliability of dried blood spot (DBS) cards in antibody measurement: A systematic review. PLoS ONE. 2021;16(3):e0248218.","journal-title":"PLoS ONE"},{"issue":"12","key":"10934_CR34","doi-asserted-by":"publisher","first-page":"e0111324","DOI":"10.1128\/spectrum.01113-24","volume":"12","author":"E Meyers","year":"2024","unstructured":"Meyers E, Coen A, Padalko E, Cools P. Short- and long-term stability of SARS-CoV-2 antibodies on dried blood spots under different storage conditions. Microbiol Spectr. 2024;12(12):e0111324.","journal-title":"Microbiol Spectr"},{"key":"10934_CR35","doi-asserted-by":"crossref","unstructured":"Longley R, MJ G, Schoffer K, Obadia T, Hyslop S, KA P et al. Plasmodium Vivax malaria serological exposure markers: assessing the degree and implications of cross-reactivity with P. knowlesi. Cell Rep Med. 2022;Accepted.","DOI":"10.1016\/j.xcrm.2022.100662"},{"key":"10934_CR36","doi-asserted-by":"publisher","first-page":"929366","DOI":"10.3389\/fmed.2022.929366","volume":"9","author":"I Byrne","year":"2022","unstructured":"Byrne I, Cramer E, Nelli L, Rerolle F, Wu L, Patterson C, et al. Characterizing the Spatial distribution of multiple malaria diagnostic endpoints in a low-transmission setting in Lao PDR. Front Med (Lausanne). 2022;9:929366.","journal-title":"Front Med (Lausanne)"},{"key":"10934_CR37","doi-asserted-by":"crossref","unstructured":"Nelli L, Surendra H, Byrne I, Ahmad R, Arisanti R, Lesmanawati D et al. Freedom from infection (FFI): enhancing decision-making for malaria elimination. BMJ Glob Health. 2024;9(12). https:\/\/gh.bmj.com\/content\/9\/12\/e014412","DOI":"10.1136\/bmjgh-2023-014412"},{"key":"10934_CR38","doi-asserted-by":"crossref","unstructured":"Stresman G, Nelli L, Wu L, Byrne I, Surendra H, Fernandez-Camacho B et al. Evidence-Based Decision-Making for Malaria Elimination: Applying the Freedom from Infection Statistical Framework in Five Malaria Eliminating Countries. 2024.","DOI":"10.2139\/ssrn.4814973"},{"key":"10934_CR39","doi-asserted-by":"crossref","unstructured":"Kartal L, Mueller I, Longley RJ. Using serological markers for the surveillance of plasmodium Vivax malaria: A scoping review. Pathogens. 2023;12(6).","DOI":"10.3390\/pathogens12060791"},{"issue":"1","key":"10934_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s13071-021-04853-9","volume":"14","author":"RPB Malijan","year":"2021","unstructured":"Malijan RPB, Mechan F, Braganza JC Jr., Valle KMR, Salazar FV, Torno MM, et al. The seasonal dynamics and biting behavior of potential Anopheles vectors of plasmodium Knowlesi in Palawan, Philippines. Parasites Vectors. 2021;14(1):357.","journal-title":"Parasites Vectors"},{"key":"10934_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/gatesopenres.12897.1","volume":"3","author":"B Greenhouse","year":"2019","unstructured":"Greenhouse B, Daily J, Guinovart C, Goncalves B, Beeson J, Bell D, et al. Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria elimination. Gates Open Res. 2019;3:1\u201317.","journal-title":"Gates Open Res"},{"key":"10934_CR42","unstructured":"World Health Organization. Diagnostic tests for detecting risk of Plasmodium vivax relapse 2024."},{"issue":"2","key":"10934_CR43","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1016\/S2666-5247(20)30197-X","volume":"2","author":"J Rosado","year":"2021","unstructured":"Rosado J, Pelleau S, Cockram C, Merkling SH, Nekkab N, Demeret C, et al. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. Lancet Microbe. 2021;2(2):e60\u20139.","journal-title":"Lancet Microbe"},{"key":"10934_CR44","doi-asserted-by":"crossref","unstructured":"Monaghan TF, Rahman SN, Agudelo CW, Wein AJ, Lazar JM, Everaert K et al. Foundational statistical principles in medical research: sensitivity, specificity, positive predictive value, and negative predictive value. Med (Kaunas). 2021;57(5).","DOI":"10.3390\/medicina57050503"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10934-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10934-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10934-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:39:08Z","timestamp":1744807148000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10934-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10934"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10934-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study documents (research protocol, information sheets and written informed consent forms) have been submitted to RITM (Philippines, approved: #2023-17), USF (USA, approved: #STUDY005669) and WEHI (Australia, approved: #HREC23\/24) IRBs for ethical approval following local guidelines. Investigators will use the latest Ethics Committee approved version of these documents at all times. The stored blood samples (DBS, EDTA-preserved whole blood, plasma) and datasets that will be collected from this study may be used in the future for new and related research such as surveillance and diagnosis of other diseases of public health importance in the Philippines, and for training of RITM staff on molecular and\/or serological assays. A new protocol will be written and IRB approval will be obtained for the use of the samples and\/or datasets for the new and related research. Participants will be allowed to withdraw their consent\/assent for the storage of their blood samples at any time.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"IM and RJL are named inventors on a patent describing P. vivax serological exposure markers (PCT\/US17\/67926). All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"539"}}